"Headquarters | GSK US" . us.gsk.com . Archived from the original on 22 May 2022. Retrieved 17 June 2022 ."GlaxoSmithKline on the Forbes Top Multinational Performers List" . Forbes . Archived from the original on 26 January 2021. Retrieved 11 December 2017 ."Global 500" . Fortune Archived from the original on 5 April 2023. Retrieved 10 August 2022 ."FTSE All-Share Index Ranking" . stockchallenge.co.uk. Archived from the original on 26 March 2023. Retrieved 10 August 2022 .Plumridge H (24 July 2014). "Glaxo Files Its Entry in Race for a Malaria Vaccine" The Wall Street Journal Archived from the original on 20 October 2020. Retrieved 13 March 2017 .
Lorenzetti L (24 July 2014). "GlaxoSmithKline seeks approval on first-ever malaria vaccine" . Fortune Archived from the original on 25 April 2016. Retrieved 16 August 2014 .
"GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data" Archived 9 September 2014 at the Wayback Machine , United States Department of Justice, 2 July 2012.
Katie Thomas and Michael S. Schmidt, "Glaxo Agrees to Pay $3 Billion in Fraud Settlement" Archived 2 March 2017 at the Wayback Machine , The New York Times
Simon Neville, "GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales" Archived 9 September 2014 at the Wayback Machine , The Guardian
Ravenscraft DJ, Long WF (January 2000). "Paths to Creating Value in Pharmaceutical Mergers" (PDF) . National Bureau of Economic Research . Archived (PDF) from the original on 7 January 2023. "GSK History" . GlaxoSmithKline. Archived from the original on 8 June 2011. Retrieved 18 April 2011 ."Eastchester: History of the Town" (PDF) . Archived from the original (PDF) on 1 April 2016."Addition to Factory" Archived 1 December 2020 at the Wayback Machine , The Eastchester Citizen-Bulletin , 19 November 1924"Iconic Burroughs Wellcome Headquarters Open for Rare Public Tour" Archived 28 August 2018 at the Wayback Machine , Triangle Modernist Houses, press release, 8 October 2012.Cummings AS (13 June 2016). "Into the Spaceship: A Visit to the Old Burroughs Wellcome Building" . Tropics of Meta historiography for the masses . Archived from the original on 11 April 2023. Retrieved 25 November 2019 . Bouton K (29 January 1989). "The Nobel Pair" . The New York Times Archived from the original on 17 October 2022. Retrieved 12 March 2020 . Stradling R (21 September 2020). "United Therapeutics to demolish an RTP landmark building" . News & Observer Archived from the original on 6 January 2021. Lesney MS (January 2004). "The ghosts of pharma past" (PDF) . Archived (PDF) from the original on 7 January 2023. Grimond M (15 June 1995). "10,000 face Glaxo's axe at Wellcome" . The Independent . Archived from the original on 6 July 2022.
Grimond M (21 June 1995). "Glaxo warns of redundancies" . The Independent . Archived from the original on 26 February 2014. Grimond M (7 September 1995). "Glaxo Wellcome plans to axe 7,500 jobs" . The Independent . Archived from the original on 24 November 2022. "Glaxo to Acquire Affymax" . The New York Times Archived from the original on 4 April 2023. Retrieved 12 March 2020 ."Outlook: Glaxo Wellcome" . The Independent . 30 March 1999. Archived from the original on 16 March 2023."Company of the week: Glaxo Wellcome" . The Independent . 1 August 1999. Archived from the original on 24 November 2022."Profile: Glaxo Wellcome" . BBC News . 17 January 2000. Archived from the original on 12 April 2023.Kleinfield NR (29 May 1984). "Smithkline: One-Drug Image" . The New York Times ISSN 0362-4331 . Archived from the original on 5 April 2023. Retrieved 30 September 2019 . "SmithKline Beckman Corp. and International Clinical Laboratories Inc. announced..." UPI . 13 April 1988. Archived from the original on 30 September 2019. Retrieved 30 September 2019 .Lohr S (13 April 1989). "SmithKline, Beecham to Merge" . The New York Times ISSN 0362-4331 . Archived from the original on 22 May 2023. Retrieved 30 September 2019 . "The new alchemy – The drug industry's flurry of mergers is based on a big gamble" . The Economist . 20 January 2000. Archived from the original on 25 July 2023."GlaxoSmithKline Completes the Purchase of Block Drug for $1.24 Billion" . PR Newswire. Archived from the original on 27 May 2014. Retrieved 1 August 2010 .{{cite web }}: CS1 maint: unfit URL (link )Stouffer R (9 October 2006). "Glaxo unit buys Breathe Right maker" . Trib Live . Archived from the original on 28 July 2013. {{cite news }}: CS1 maint: unfit URL (link )"Sir Christopher Gent to exit GlaxoSmithKline" . The Telegraph . 28 October 2012. Archived from the original on 4 April 2023. Retrieved 10 September 2023 .Ben Hirschler (24 May 2007). "Glaxo China R&D centre to target neurodegeneration" . Reuters . Archived from the original on 11 August 2021. Retrieved 5 July 2021 . Cyranoski D (29 October 2008). "Pharmaceutical futures: Made in China?" . Nature . Archived from the original on 10 June 2015. Retrieved 13 July 2012 . "Corporate Executive Team" , GlaxoSmithKline. Retrieved 16 November 2013. Archived 14 October 2012 at the Wayback Machine "Andrew Witty's journey from Graduate to GSK CEO" Archived 9 February 2017 at the Wayback Machine , GlaxoSmithKline, 12 August 2008; "Andrew Philip Witty" Archived 20 December 2020 at the Wayback Machine , Bloomberg ."FDA Approves Additional Vaccine for 2009 H1N1 Influenza Virus" . US Food and Drug Administration (FDA) . 16 November 2009. Archived from the original on 19 November 2009.{{cite web }}: CS1 maint: unfit URL (link )"GSK Acquires Laboratorios Phoenix for 3m | InfoGrok" . infogrok.com . 14 June 2010. Archived from the original on 14 June 2010. Retrieved 10 September 2023 .Sandle P (13 December 2010). "UPDATE 2-Glaxo buys protein-drinks firm Maxinutrition" . Reuters . Archived from the original on 16 December 2010. Ranii D (21 December 2011). "GSK sells BC, Goody's and other brands" . News & Observer . Archived from the original on 15 April 2012. "GSK confirms 500 mln stg UK investment plans" . Reuters . 22 March 2012. Archived from the original on 5 April 2023. Retrieved 10 September 2023 .European Biotechnology News 16 May 2012. GSK acquires Cellzome 100%: Britain's largest drugmaker GlaxoSmithKline will pay about €75m in cash to acquire Cellzome AG completely Archived 4 June 2016 at the Wayback Machine ; John Carroll for FierceBiotech 15 May 2012 GSK snags proteomics platform tech in $98M Cellzome buyout Archived 4 June 2016 at the Wayback Machine John Carroll for FiercePharma. 12 June 2012 GSK continues deal spree with $302M pact for Basilea eczema drug Archived 29 May 2014 at the Wayback Machine ; Basilea Pharmaceutica Press Release. 11 June 2012 Basilea enters into global agreement with Stiefel, a GSK company, for Toctino (alitretinoin) Archived 4 March 2016 at the Wayback Machine Monaghan A (9 September 2013). "Ribena and Lucozade sold to Japanese drinks giant" . The Guardian . ISSN 0261-3077 . Archived from the original on 5 April 2023. Retrieved 10 September 2023 . Hirschler B (10 March 2014). "GSK pays $1 billion to lift Indian unit stake to 75 percent" . Reuters . Archived from the original on 5 April 2023. Retrieved 10 March 2014 . Bray C, Jolly D (23 April 2014). "Novartis and Glaxo Agree to Trade $20 Billion in Assets" . The New York Times Archived from the original on 5 April 2023. Retrieved 12 March 2020 . "GEN - News Highlights:GSK Acquires GlycoVaxyn for $190M" . GEN . 11 February 2015. Archived from the original on 3 April 2023."Pfizer Buys Two GSK Meningitis Vaccines for $130M" . GEN . 22 June 2015. Archived from the original on 31 March 2023. Retrieved 25 March 2016 .Quinn J (25 September 2014). "Sir Philip Hampton to chair Glaxo" . The Telegraph . Archived from the original on 4 April 2023. Retrieved 10 September 2023 . Yeomans J (20 September 2016). "Emma Walmsley becomes latest female CEO in FTSE 100 as she replaces Sir Andrew Witty at GSK" The Telegraph . Daily Telegraph, London. Archived from the original on 21 September 2016. Retrieved 20 September 2016 . "GlaxoSmithKline boosts stake in Saudi Arabia unit" . Reuters . 18 December 2017. Archived from the original on 4 April 2023."GlaxoSmithKline considers splitting up the group - FT" . Reuters . 21 July 2018. Archived from the original on 21 July 2018. Retrieved 23 July 2018 .Gruber KW (28 November 2018). "Unilever in pole position to swallow GSK's Indian Horlicks business" . Reuters . Archived from the original on 28 November 2018. Retrieved 28 November 2018 . Sagonowsky E (28 November 2018). "GlaxoSmithKline taps Unilever as lead bidder in Indian Horlicks buyout: report" . FiercePharma. Archived from the original on 5 April 2023. Retrieved 28 November 2018 . "Unilever swallows GSK's Indian Horlicks business for $3.8 billion" . Reuters . 3 December 2018. Archived from the original on 3 December 2018. Retrieved 3 December 2018 .Hirschler B (3 December 2018). "GSK slides after buying cancer firm Tesaro for hefty $5.1 billion" . Reuters . Archived from the original on 3 December 2018. Retrieved 3 December 2018 . Sagonowsky E (21 October 2019). "Zeroing in on fast-growing vaccines, GSK sheds 2 shots to Bavarian Nordic for up to $1.1B" . FiercePharma . Archived from the original on 5 January 2020. Retrieved 26 January 2020 . "GSK agrees to divest rabies and tick-borne encephalitis vaccines to Bavarian Nordic" . GSK . 21 October 2019. Archived from the original on 4 August 2023. Retrieved 26 January 2020 .Schuetze A, Aripaka P (20 July 2020). "GSK buys 10% of CureVac in vaccine tech deal" . Reuters . Archived from the original on 20 July 2020 – via uk.reuters.com. Shields M (27 March 2018). "GSK buys out Novartis in $13 billion consumer healthcare shake-up" . Reuters . Archived from the original on 27 March 2018. Retrieved 27 March 2018 . Hirschler B (19 December 2018). "Drugmaker GSK to split after striking Pfizer consumer health deal" . Reuters . Archived from the original on 19 December 2018. Retrieved 19 December 2018 . Freeman S (22 February 2022). "Hello, Haleon: GlaxoSmithKline reveals name of £60bn consumer health spin-out" . Evening Standard . Archived from the original on 5 April 2023. Retrieved 23 February 2022 . Cavale S, Burger L, Dey M (15 January 2022). "GSK rejects 50-billion-pound Unilever offer for consumer assets" . Reuters . Archived from the original on 15 January 2022 – via www.reuters.com. Grover N, Shabong Y (13 April 2022). "GSK to buy Sierra Oncology amid pressure to boost drug pipeline" . Reuters . Archived from the original on 13 April 2022 – via www.reuters.com. Keown A (31 May 2022). "GSK Bolsters Vaccines Business with $3.3B Affinivax Buy" . Biospace . Archived from the original on 5 February 2023. Retrieved 9 June 2022 . "Change of name" . London Stock Exchange. 16 May 2022. Archived from the original on 17 May 2022. Retrieved 2 June 2022 .Susin M (18 April 2023). "GSK: To Acquire The Late-stage Biopharmaceutical Group For $14.75 Per Share" . MarketWatch . Archived from the original on 18 April 2023. Retrieved 18 April 2023 . {{cite web }}: CS1 maint: unfit URL (link )"Most-recognized brands: Anti-infectives, December 2013" . Drugs.com. Archived from the original on 27 January 2023."mupirocin search results" . DailyMed . Archived from the original on 4 December 2020. Retrieved 12 March 2020 ."Chemical & Engineering News: Top Pharmaceuticals: 6-Mercaptopurine" . pubsapp.acs.org . Archived from the original on 1 June 2023. Retrieved 11 September 2023 ."George Hitchings and Gertrude Elion" . Science History Institute. June 2016. Archived from the original on 9 June 2023.Altman LK (23 February 1999). "Gertrude Elion, Drug Developer, Dies at 81" . The New York Times Archived from the original on 17 October 2009. "Press release: Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children" . PATH. Archived from the original on 15 April 2018. Retrieved 13 May 2014 ."Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children" . GlaxoSmithKline. Archived from the original on 7 April 2014.McNeil DG Jr (18 October 2011). "Scientists See Promise in Vaccine for Malaria" . The New York Times Archived from the original on 5 April 2023.Smith A (27 March 2014). "Alli, a popular weight-loss drug, is recalled by maker GlaxoSmithKline for possible tampering" . CNNMoney . Archived from the original on 28 March 2014. Retrieved 11 September 2023 . "About us: what we do" , GlaxoSmithKline, accessed 16 November 2013 Archived 13 October 2013 at the Wayback Machine "Coronavirus vaccine: UK signs deal with GSK and Sanofi" . BBC News . 29 July 2020. Archived from the original on 29 July 2020.Lovelace Jr B (31 July 2020). "U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccine" . CNBC. Archived from the original on 1 August 2020. Keown A (11 September 2019). "GSK to Acquire Celiac-Focused Sitari Pharmaceuticals" . BioSpace . Archived from the original on 22 September 2019. "The Nobel Prize in Physiology or Medicine 1936" . NobelPrize.org . Archived from the original on 26 August 2018."The Nobel Prize in Physiology or Medicine 1982" . NobelPrize.org . Archived from the original on 20 February 2019."Access to medicine" (PDF) . Archived from the original (PDF) on 7 February 2014.Human Rights Campaign. Profile: Buyers Guide entry for GlaxoSmithKline Archived 13 May 2016 at the Wayback Machine . Accessed 16 May 2014 "Global alliance to eliminate Lymphatic Filariasis" . Ifpma.org. Archived from the original on 27 December 2008."Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020" . Bill & Melinda Gates Foundation. 30 January 2012. Archived from the original on 14 March 2013. Retrieved 30 May 2013 .
"Research-based pharma pledges on neglected tropical diseases" . The Pharma Letter . 31 January 2012. Archived from the original on 19 July 2012. Retrieved 30 May 2013 .
"Global programme to eliminate lymphatic filariasis: progress report, 2014" (PDF) . World Health Organization. 18 September 2015. p. 490. Archived from the original (PDF) on 17 October 2015.Boseley S (13 February 2009). "Drug giant GlaxoSmithKline pledges cheap medicine for world's poor" . The Guardian . ISSN 0261-3077 . Archived from the original on 5 September 2013. Retrieved 11 September 2023 . UNITAID 16 February 2009. UNITAID Statement on GSK Patent Pool For Neglected Diseases Archived 27 May 2014 at the Wayback Machine "The Guardian: Letter in response to GSK's patent pool proposal" . Médecins Sans Frontières Access Campaign . 24 February 2009. Archived from the original on 20 June 2019. Retrieved 11 September 2023 ."GlaxoSmithKline unit joins patent pool for AIDS drugs | Reuters" . Reuters . 27 February 2013. Archived from the original on 4 April 2023."Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval" . Medicines Patent Pool . 1 April 2014. Archived from the original on 2 June 2023.Palmer E (17 January 2018). "GSK cutting jobs in sub-Saharan Africa, will rely on distributors" . Fierce Pharma . Archived from the original on 18 January 2018. Retrieved 10 January 2023 . Mwangi K (15 October 2022). "GSK stops Nairobi production as high costs and low sales eat into revenue" . The East African . Archived from the original on 9 June 2023. Retrieved 9 March 2023 . LaHatte G (2011). "Reverse Payments: When the Federal Trade Commission can Attack the Validity of Underlying Patents" . Case Western Reserve Journal of Law, Technology & the Internet . 2 : 37–73. Archived from the original on 18 November 2020. Retrieved 19 June 2015 . United States v. Glaxo Group Ltd .Archived 4 December 2020 at the Wayback Machine at 62-63.Oliver Thring, "Consider squash and cordial" Archived 10 May 2017 at the Wayback Machine , The Guardian
"We have Frank and Vernon to thank for Ribena" Archived 18 April 2015 at the Wayback Machine , The Bristol Post , 17 September 2013.
Gregoriadis L (18 January 2001). "Makers of Ribena lose fight over anti-decay claims" . The Telegraph . Archived from the original on 24 March 2010. Retrieved 11 September 2023 . Eames D (28 March 2007). "Judge orders Ribena to fess up" . The New Zealand Herald Archived from the original on 18 June 2018. Retrieved 15 April 2018 .
Tony Jaques, "When an Icon Stumbles – The Ribena Issue Mismanaged" Archived 4 March 2016 at the Wayback Machine , Corporate Communications: An International Journal , 13(4), 2008, pp. 394–406.
Michael Regester, Judy Larkin, Risk Issues and Crisis Management in Public Relations , Kogan Page Publishers, 2008, p. 67ff .
"Office of Public Affairs | GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant | United States Department of Justice" . www.justice.gov . 26 October 2010. Archived from the original on 19 October 2014. Retrieved 11 September 2023 .Harris G, Wilson D (26 October 2010). "Glaxo to Pay $750 Million for Sale of Bad Products" . The New York Times Archived from the original on 5 April 2023. "The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix" . The Swedish Medical Products Agency . 18 August 2010. Archived from the original on 17 February 2011. Retrieved 19 August 2010 .Report from an epidemiological study in Sweden on vaccination with Pandemrix and narcolepsy Archived 15 December 2018 at the Wayback Machine , Swedish medical product agency, 30 June 2011."THL: Pandemrixilla ja narkolepsialla on selvä yhteys" . Mtv3.fi . Archived from the original on 2 June 2020. Retrieved 8 September 2018 ."Terveyden ja hyvinvoinnin laitos - THL" . Terveyden ja hyvinvoinnin laitos . Archived from the original on 5 September 2012. Retrieved 8 September 2018 ."Narkolepsia ja sikainfluenssarokote - THL" . Terveyden ja hyvinvoinnin laitos . Archived from the original on 17 May 2013. Retrieved 8 September 2018 ."Statistikdatabas för dödsorsaker (den öppna delen av dödsorsaksregistret)" (in Swedish). Socialstyrelsen. Archived from the original on 13 February 2021. Retrieved 24 March 2020 .Lintern S (20 July 2015). "DH funds private prescriptions for drug denied to NHS patients" . Health Service Journal. Archived from the original on 25 February 2021. Retrieved 20 July 2015 . Max Baucus , Chuck Grassley , "Finance Committee Letter to the FDA Regarding Avandia" Archived 5 August 2010 at the Wayback Machine , United States Senate Finance Committee, 12 July 2010."Inside GSK's CASSPER Ghostwriting Program" Archived 6 December 2014 at the Wayback Machine , CBS News, 21 August 2009."GSK to stop paying doctors in major marketing overhaul" Archived 28 October 2014 at the Wayback Machine , Thomson/Reuters, 17 December 2013."United States Senate Committee on Finance Report: The Intimidation of Dr. John Buse and the Diabetes Drug Avandia" . www.finance.senate.gov . Archived (PDF) from the original on 11 November 2016. Retrieved 11 September 2023 .Max Baucus , Chuck Grassley , "Finance Committee Letter to the FDA Regarding Avandia" Archived 5 August 2010 at the Wayback Machine , United States Senate Finance Committee, 12 July 2010; for internal concerns, p. 2 and attachment E, pp. 20–35; for ghostwriting, p. 3 and attachment H, pp. 58–109; for the ghostwriting, attachment I, p. 110ff; for cover letter to Circulation
Haffner SM, Greenberg AS, Weston WM, et al. (August 2002). "Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus" . Circulation . 106 (6): 679–84. doi :10.1161/01.CIR.0000025403.20953.23 PMID 12163427 .
Home PD, Pocock SJ, Beck-Nielsen H, et al. (June 2009). "Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial". Lancet . 373 (9681): 2125–35. doi :10.1016/S0140-6736(09)60953-3 . PMID 19501900 . S2CID 25939495 .
Home PD, Pocock SJ, Beck-Nielsen H, et al. (September 2005). "Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol" . Diabetologia . 48 (9): 1726–35. doi :10.1007/s00125-005-1869-1 PMID 16025252 .
"RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes - Full Text View" . ClinicalTrials.gov . 21 March 2017. Archived from the original on 17 June 2018. Retrieved 12 March 2020 .
Saul S (30 January 2008). "Doctor Accused of Leak to Drug Maker" . The New York Times Archived from the original on 5 April 2023. Retrieved 12 March 2020 . Harris G (22 February 2010). "A Face-Off on the Safety of a Drug for Diabetes" . The New York Times Archived from the original on 5 June 2023. Retrieved 12 March 2020 . "Staff report on GlaxoSmithKline and the diabetes drug Avandia" Archived 6 December 2014 at the Wayback Machine , Committee on Finance, United States Senate, January 2010.
"Grassley, Baucus Release Committee Report on Avandia" Archived 6 December 2014 at the Wayback Machine , The United States Senate Committee on Finance, 20 February 2010.
Andrew Clark, "Glaxo's handling of Avandia concerns damned by US Senate committee" Archived 6 December 2014 at the Wayback Machine , The Guardian
David Graham , "Assessment of the cardiovascular risks and health benefits of rosiglitazone" Archived 17 May 2017 at the Wayback Machine , Office of Surveillance and Epidemiology, Food and Drug Administration, 30 July 2007."FDA Adds Boxed Warning for Heart-related Risks to Anti-Diabetes Drug Avandia" . U.S. Food and Drug Administration . 14 November 2007. Archived from the original on 18 June 2009."FDA Drug Safety Communication: FDA requires removal of some prescribing and dispensing restrictions for rosiglitazone-containing diabetes medicines" . Food and Drug Administration. 25 November 2013. Archived from the original on 24 April 2019. Retrieved 16 December 2019 .Avandia. Prescribing information" Archived 27 March 2019 at the Wayback Machine , Food and Drug Administration."European Medicines Agency recommends suspension of Avandia, Avandamet and Avaglim" . European Medicines Agency . 17 September 2018. Archived from the original on 29 June 2019. Retrieved 11 September 2023 ."FDA requires removal of certain restrictions on the diabetes drug Avandia" Archived 4 May 2015 at the Wayback Machine , Food and Drug Administration, 25 November 2013.
"Readjudication of the Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycemia in Diabetes Trial (RECORD)" Archived 9 May 2017 at the Wayback Machine , Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Food and Drug Administration, 5–6 June 2013.
Steven Nissen, "Steven Nissen: The Hidden Agenda Behind The FDA's New Avandia Hearings" Archived 8 May 2017 at the Wayback Machine , Forbes
"The FDA Responds To Steve Nissen's Criticism Of Upcoming Avandia Meeting" Archived 20 March 2017 at the Wayback Machine , Forbes
Letter showing authorship of Study 239 Archived 5 May 2015 at the Wayback Machine , Drug Industry Document Archive, University of California, San Francisco.
Isabel Heck, "Controversial Paxil paper still under fire 13 years later" Archived 5 May 2015 at the Wayback Machine , The Brown Daily Herald , 2 April 2014.
Jureidini JN, McHenry LB, Mansfield PR (2008). "Clinical trials and drug promotion: Selective reporting of study 329". International Journal of Risk & Safety in Medicine . 20 (1–2): 73–81. doi :10.3233/JRS-2008-0426 .
"Company hid suicide link" Archived 4 May 2015 at the Wayback Machine , BBC News, 29 January 2007; "Secrets of the Drug Trials," BBC Panorama, 29 January 2007; Goldacre 2013, pp. 296–297.
Keller M , et al. (July 2001). "Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial" (PDF) . Journal of the American Academy of Child and Adolescent Psychiatry . 40 (7): 762–772. doi :10.1097/00004583-200107000-00010 . PMID 11437014 . Archived (PDF) from the original on 12 February 2021. Retrieved 27 April 2015 .Angell M (15 January 2009). "Drug Companies & Doctors: A Story of Corruption" . The New York Review of Books . Vol. 56, no. 1. Archived from the original on 28 August 2023."Judge: Paxil ads can't say it isn't habit-forming" . Associated Press. 20 August 2002. Archived from the original on 14 July 2003.{{cite news }}: CS1 maint: unfit URL (link )Drug and Device Law. 14 December 2006 The FDA's Amicus Briefs on Preemption Archived 29 September 2015 at the Wayback Machine
Ronald D. White for the Los Angeles Times. 21 August 2002 U.S. Opposes Order to Pull Paxil TV Ads Archived 17 October 2015 at the Wayback Machine
"WHO Expert Committee on Drug Dependence" , Thirty-third Report, World Health Organization, 2003, pp. 20, 25.Alice Yan, Toh Han Shih (16 July 2013). "Shanghai travel agent's revenue surge led to arrests in GSK bribery case" . South China Morning Post . Archived from the original on 19 November 2017. Retrieved 17 July 2013 . "GlaxoSmithKline executives face China bribery probe" . BBC News . 11 July 2013. Archived from the original on 11 February 2021. Retrieved 20 June 2018 .Rupert Neate and Angela Monaghan, "GlaxoSmithKline admits some staff in China involved in bribery" Archived 16 September 2016 at the Wayback Machine , The Guardian
Rupert Neate, "GSK's China crisis: chief executive Andrew Witty speaks - as it happened" Archived 11 August 2016 at the Wayback Machine , The Guardian
Philips T (26 July 2013). "Chinese police allege Glaxo sales reps trained to offer sexual bribes" The Daily Telegraph . Archived from the original on 11 January 2022.
Bradsher K, Buckley C (19 September 2014). "China Fines GlaxoSmithKline Nearly $500 Million in Bribery Case" . The New York Times Archived from the original on 8 April 2023. Moore M, Roland D (19 September 2014). "China fines Glaxo £297m for bribery, Mark Reilly sentenced" . The Telegraph . Archived from the original on 4 April 2023. Retrieved 11 September 2023 . Hooper J, Stewart H (27 May 2004). "Over 4,000 doctors face charges in Italian drugs scandal" . The Guardian . Archived from the original on 31 August 2022. Retrieved 31 August 2022 . "Glaxo probed over doctor freebies" . BBC News . 12 March 2002. Archived (PDF) from the original on 17 October 2015. Retrieved 31 August 2022 ."GlaxoSmithKline Annual Report 2008" (PDF) . p. 177. Archived (PDF) from the original on 26 November 2017. Retrieved 8 October 2015 ."GlaxoSmithKline to Settle Tax Dispute With U.S." Archived 29 March 2017 at the Wayback Machine , Reuters, 12 September 2006"IRS Accepts Settlement Offer in Largest Transfer Pricing Dispute" Archived 13 November 2020 at the Wayback Machine , IRS, 11 September 2006.Kollewe J (28 May 2014). "GlaxoSmithKline faces criminal investigation by Serious Fraud Office" . The Guardian . Archived from the original on 5 December 2020. Retrieved 11 December 2016 . Ridley K (23 July 2014). "UK fraud office liaising with China on GSK bribery case" . Reuters . Archived from the original on 21 February 2022. Retrieved 31 August 2022 . "GlaxoSmithKline faces bribery claims in Syria" The Telegraph . Reuters. 12 August 2014. Archived from the original on 18 June 2018. Retrieved 31 August 2022 .Davies R (6 October 2020). "GSK tells UK staff: turn off Covid test-and-trace app while at work" . TheGuardian.com Archived from the original on 3 February 2021. Retrieved 6 October 2020 . 